December 2020 - Page 3 of 4 - BioMedWire (BMW)

MondayDec 14, 2020 2:15 pm

Researchers Discover How Coronavirus Triggers Silent Hypoxia

There are some aspects of the coronavirus that scientists do not know enough about, seeing as it’s a completely new virus that attacks the lungs as well as other parts of the body. However, the strides that have been made in the last few months with regard to research — and now a vaccine — are a clear indication that researchers are working hard to discover as much as they can. Recently, University of Vermont collaborators and biomedical engineers from Boston University discovered have studied how the coronavirus causes silent hypoxia in patients. Hypoxia is a condition that causes abnormally…

MondayDec 14, 2020 1:32 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Innovative Technology to Change Current Standard of Care for Bladder Cancer Patients

The company’s proprietary technology could change the way surgeons handle cystoscopy procedures by displaying white light and blue light images side-by-side on one screen The technology is primarily promoted as an imaging device for bladder cancer but has the potential to expand to other endoscopic procedures including laparoscopic, colorectal and thoracic Bladder cancer is the sixth most prevalent cancer in the United States, with 600,000 people fearing recurrence The global market for bladder cancer is estimated to grow to an estimated $4.71 billion by 2026 The current standard of care for bladder cancer is minimally invasive surgery (MIS)uses white light…

FridayDec 11, 2020 1:15 pm

What You Should Know About Chronic Rhinitis

Ever heard of chronic rhinitis? No? Well, it’s a condition that results in the inflammation of the inner lining of your nose. It can last for more than a month, and statistics show that 77 million individuals in America have the disease. Chronic rhinitis is not acute rhinitis, which only lasts several days. There are two types of chronic rhinitis: the non-allergic and allergic types. An estimated 19 million individuals in America suffer from the less common non-allergic type while the remaining 58 million have the allergic type, making the latter very common. We discuss both types below. Non-allergic chronic…

FridayDec 11, 2020 1:12 pm

CannAssist International (CNSC) Prepares to Take CBD Product Market by Storm

CannAssist International’s Xceptor Labs is active player within CBD-based product sector Global CBD product market is expected to rise in value from $4.6 billion in 2018 to over $23 billion by 2025 Xceptor Labs differentiating product range through use, development of proprietary CiBiDinol technology CiBiDinol technology covers the oil soluble CBD molecule with a water soluble carrier thereby increasing its bioavailability and enabling easier absorption of product Xceptor Labs has recently launched its Xceptol product line, comprised of topical pain creams, CBD-derived capsules, tinctures and pet drops CannAssist International (OTCQB: CNSC) is a biotechnological pharmaceutical and wellness company which has…

ThursdayDec 10, 2020 12:44 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Brain Cancer Drug IND Filing Accepted for Review by FDA

CNS Pharmaceuticals featured in audio broadcast distributed to thousands of syndication points. Berubicin IND accepted for review by FDA Phase 1 trial showed 44% of patients experiencing clinical benefit of stable disease or better Adult Phase 2 trials to commence in Q1 2021 The IND filing for brain cancer drug Berubicin has been accepted for review by the U.S. Food and Drug Administration (“FDA”), reports CNS Pharmaceuticals (NASDAQ: CNSP), the company now responsible for the drugs’ development. That news was featured in a recent syndicated NetworkNewsAudio (“NNA”) broadcast, which covered CNS Pharmaceuticals’ recent submission of an Investigational New Drug (“IND”)…

ThursdayDec 10, 2020 12:30 pm

How to Prevent Injuries During Your Workout

People work out for different reasons. Some want to keep fit and healthy whiles others have aesthetic in mind; still others may be training for an upcoming competition or event. Doctors recommend working out to maintain good health, advising that we make it part of our daily routines. A good workout plan should factor in the risk of injury and how to avoid it. Injuries only impede your progress. To avoid this, here are some ways you can avoid injuries whe working out. Stretch and do warm-up exercises before you begin. Taking a few minutes to warm up helps your…

ThursdayDec 10, 2020 12:26 pm

Predictive Oncology (NASDAQ: POAI) Releases Third-Quarter 2020 Business Update, Financial Report

Financial numbers show revenues stay level, gross margins up and operations expenses down. Company continues focus on primary mission of applying artificial intelligence to precision medicine, drug discovery. POAI subsidiaries all showing progress, growth in key areas. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has released its Q3 2020 financial report along with an update of company accomplishments and achievements (https://ibn.fm/HCpQM). In the report, POAI CEO Dr. Carl Schwartz noted milestones for each of the company’s subsidiaries: Helomics, TumorGenesis, Soluble Biotech and Skyline Medical. “Our operating cash improved…

WednesdayDec 09, 2020 2:26 pm

RYAH Group Inc. Is ‘One to Watch’

RYAH Group is a technological leader in the plant-based treatment market with its unique combination of proprietary IoT devices and data analytics, supported by patented AI technology The company’s products pair a growing ecosystem of therapeutic plants with top-rated apps, devices and services RYAH offers a complete remote dosage delivery and dose-monitoring platform based on data-driven analytics supported by prescribing doctors and their patients The company is finalizing its anticipated listing on the Canadian Securities Exchange RYAH holds a unique position on the $100.3 billion medical plant market, with the potential to capture footholds in both the IoT and Data…

WednesdayDec 09, 2020 2:00 pm

Brain Scientific Inc. (BRSF) New Management to Play Key Role in Advancing Commercialization, Growing Revenue

BRSF enhances executive team with new strategy, marketing VPs. New market opportunity created with demand for remote EEG testing due to COVID-19. Brain Scientific has developed NeuroCap(TM), a revolutionary, hospital-grade disposable EEG headset. Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, strengthened its executive team with the appointment of two proven sales and marketing figures. The two management additions include Amy Griffith, the new vice president of strategy and business development, who will lead the development of strategic and tactical initiatives (https://ibn.fm/Stz6j), and Stuart Bernstein, the new vice president of marketing, who will be responsible for BRSF’s…

WednesdayDec 09, 2020 2:00 pm

Georgia State Researchers Develop Drug That Can Stop Coronavirus Transmission

Scientists at the Georgia State University Institute for Biomedical Sciences have found that the MK-4482/EIDD-2801 antiviral drug, which was developed to treat the SARS-CoV-2 infection, completely stops transmission of the virus in 24 hours. The researchers, led by distinguished Georgia State University professor Dr. Richard Plemper, initially discovered that the drug was strong against influenza viruses. Plemper explains that this was the first test for a drug that is orally available and that can stop the transmission of SARS-CoV-2. He adds that MK-4482/EIDD-2801 may be a game-changer. Stopping the transmission of the SARS-CoV-2 virus on a wide scale until vaccination…